Neurology & Brain Health Accredited in India
ALS Icon

Investigational Stem Cell Therapy for ALS in India

Regenerative Research, Advanced Rehabilitation & Comprehensive Care for Motor Neuron Disease

PROTOCOL SNAPSHOT
Recommended Stay: 4 to 7 Days in India
Treatment Route: Combined Infusion
Package Cost in India: $4,500 - $7,500 USD
Cell Types: Autologous/ethically sourced MSCs
Quality: cGMP cleanrooms, IEC Standards
Send Reports For Free Quote
NK

Medically Reviewed & Fact-Checked

Clinical E-E-A-T Verified
Clinically Reviewed by: Dr. N Kumar, DM (Neurology) | Medical Registration Verified

Partner Facility: JCI & NABH Accredited Tertiary Centers, New Delhi & Mumbai, India. All cell protocols operate under Institutional Ethics Committee (IEC) clearance and comply with ICMR research frameworks.

Last Audited: March 2026 View Editorial Standards →
Important Regulatory Notice: Stem cell therapy for Amyotrophic Lateral Sclerosis (ALS) is currently classified as an investigational cellular intervention under Institutional Ethics Committee (IEC) oversight. It is not an absolute cure for ALS, but serves as an adjuvant neuroprotective protocol designed to slow functional decline and support muscular-motor coordination.
1. Overview & Realistic Expectations

Overview & Realistic Expectations

Investigational Stem Cell Therapy for ALS in India • Regenerative Research, Advanced Rehabilitation & Comprehensive Care for Motor Neuron Disease

Amyotrophic Lateral Sclerosis (ALS) is a progressive neurodegenerative condition affecting voluntary muscle control. While standard therapies (such as Riluzole and non-invasive ventilation) focus on managing symptoms and slowing decline, cell-based clinical protocols investigate neuroprotection and microenvironment modulation.

Protocol Nature
Investigational and adjuvant
(designed to support, not replace, standard neurological care).
Primary Objective
Functional Stabilization
Aimed at slowing functional decline, preserving motor neuron stability, and supporting quality of life—this is not an established clinical cure.
Cell Types & Quality
cGMP Cleanrooms
Autologous bone marrow-derived or ethically sourced mesenchymal stem cells (MSCs), harvested and prepared in certified cGMP cleanrooms under Institutional Ethics Committee (IEC) clearance.
2. Who is Eligible for Evaluation?

Who is Eligible for Evaluation?

Every international patient undergoes an advance multidisciplinary review prior to travel:

Confirmed Diagnosis
Clinically definite or probable ALS according to revised El Escorial criteria.
Pulmonary Function
Sufficient respiratory reserve, typically with a Forced Vital Capacity (FVC) above 50% (evaluated individually).
Medical Stability
Absence of active systemic infections, malignancy, or acute cardiovascular instability.
Travel Clearance
Fit to travel internationally with or without a medical escort.
3. Observed Clinical Goals & Potential Improvements

Observed Clinical Goals & Potential Improvements

Under rigorous medical guidelines, outcomes are evaluated in terms of stabilization and functional preservation rather than complete reversal:

Temporary Deceleration of Functional Decline
Aimed at flattening or slowing the rate of decline on the standardized ALSFRS-R (Revised ALS Functional Rating Scale), particularly across the first 3 to 6 months post-administration.
Preservation of Respiratory Stability
Intended to help stabilize pulmonary dynamics and slow the deterioration of Forced Vital Capacity (FVC) alongside non-invasive ventilatory support.
Reduction in Muscle Spasticity and Cramping
Trophic and paracrine factor secretion by MSCs may decrease localized neuroinflammation, helping alleviate distressing spastic tone and fasciculations.
Modest Energy and Endurance Gains
Patients frequently report transient reductions in generalized daily fatigue and improved stamina for basic activities of daily living (ADLs).
Bulbar Functional Support
For individuals with early-stage bulbar symptoms, protocol goals focus on slowing the rate of speech fragmentation (dysarthria) and preserving swallowing coordination (dysphagia).
Enhanced Rehabilitation Tolerance
By reducing microenvironmental neurotoxicity and inflammation, patients often show better receptivity and participation during physical and occupational therapy.
Clinical Video Case Study

Patient Experience: Speech Improved for ALS Patient from Kuwait

Watch this clinical case study demonstrating observed functional speech improvement and rehabilitation outcomes at Stem Cell Therapy Center India.

Visit YouTube Channel
Observed Clinical Impact: Noticeable improvement in articulation, speech clarity, and day-to-day communication following cellular therapy protocols. Individual clinical responses vary based on disease stage and baseline progression.
Clinical Note for Patients: Because ALS is biologically complex and heterogeneous, individual responses vary widely depending on disease duration, progression speed, and baseline respiratory function.
4. Why Choose Our Center in India?

Why Choose Our Center in India?

Hospital infrastructure, accreditation, and specialized clinical leadership:

Feature What We Provide
Accredited Centers Procedures performed exclusively within tertiary-care hospitals accredited by JCI and NABH.
Neurology Leadership Care directed by board-certified neurologists (DM/DNB) with focused expertise in neuromuscular disorders.
Cleanroom Quality Cell processing conducted strictly in cGMP cleanrooms meeting international viability and sterility standards.
Comprehensive Care Simultaneous access to intensive care units (ICU), pulmonary specialists, and specialized physical therapy.
Cost Transparency Clear, bundled international package pricing with no hidden facility surcharges.
5. Estimated Treatment Costs in India

Estimated Treatment Costs in India

Clear, transparent international package pricing with comprehensive inpatient inclusions:

Cost Range Transparent Pricing
$4,500 - $7,500 USD

(individual pricing depends on autologous vs. allogeneic protocols, and required supportive therapies).

Clinical Goal Investigational Protocol
Functional Preservation

(Aimed at neuroprotection, slowing ALSFRS-R functional decline, and symptom support).

Package Inclusions:

Pre-procedure baseline testing (PFT, blood panels), cell harvesting and cGMP cleanroom processing, targeted administration, inpatient hospital stay, and daily neuro-rehabilitation.

6. Dedicated Services for International Patients

Dedicated Services for International Patients

Traveling across borders with a neurodegenerative condition requires specialized attention. We provide end-to-end patient coordination to ensure a smooth, stress-free clinical stay:

Medical Visa (MED & MED-X)

24–48 Hrs

Official hospital visa invitation letters issued promptly for the patient and up to two attendants to expedite embassy approval.

Dedicated Patient Navigator

1-on-1 Care

A single designated point of contact coordinating hospital appointments, medical consultations, logistics, and family support throughout your stay.

Multilingual Interpreters

Language Support

Fluent English clinical staff, with dedicated professional interpreters available for Arabic, Russian, French, and other international languages.

Dietary & Dysphagia Support

Clinical Nutrition

Tailored meal plans accommodating cultural preferences (Halal, Vegetarian, Western) and specialized texture-modified diets for swallowing difficulties.

Currency Exchange & Local Connectivity

Hassle-Free Arrival

Full assistance with high-speed local 5G SIM cards, airport/hospital currency exchange counters, and international payment processing (bank wire, debit/credit cards).

Comprehensive assistance from initial inquiry through discharge & home follow-up.
Connect with Coordinator →
7. Logistics, Travel & Accommodation Support

Logistics, Travel & Accommodation Support

We make long-distance transit as smooth, safe, and comfortable as possible for mobility-impaired patients and accompanying family members:

Transit & Mobility

Airport & Local Transportation

Private & AC
Chauffeured Airport Transfers

Private airport pick-up and drop-off in spacious, wheelchair-accessible air-conditioned vehicles directly to hospital or hotel.

Ramp & Tarmac
Wheelchair & Stretcher Support

Pre-arranged tarmac escorts, ambulift assistance, and ramp boarding support at international terminals for seamless arrival.

ACLS Standby
Ambulance Coordination

Advanced Cardiac Life Support (ACLS) ICU ambulance transport with medical escort available for high-dependency patients.

Lodging & Stay

Accommodation Options

Partner Hotels & Serviced Apartments

5–10 Mins from Hospital Special Medical Rates

Discounted rates at vetted 4-star and 5-star partner hotels located within 5–10 minutes from the hospital. Features include step-free wheelchair-accessible elevators, roll-in showers, accessible corridors, and kitchenette facilities tailored for extended family stays.

Need flight medical clearance (MEDIF) or specialized stretcher booking? Our logistics team assists directly.
Get Travel Assistance →
8. The International Patient Journey

The International Patient Journey

End-to-end structured clinical pathway from initial records review to long-term monitoring:

Step 1 Remote Assessment
  • • Medical record review
  • • Eligibility confirmation
  • • Itemized cost estimate
Step 2 Travel Planning
  • • Visa invitation letter
  • • Flight & hotel booking
  • • Airport reception
Step 3 In-Clinic Care
  • • Neuro assessment
  • • Procedure & rehab
  • • Discharge plan
Step 4 Long-Term Monitoring
  • • 1, 3, 6, 12 month reviews
  • • Direct home doctor link
9. Safety Standards & Regulatory Compliance

Safety Standards & Regulatory Compliance

Rigorous medical governance under Indian Council of Medical Research (ICMR) principles:

ICMR Research Framework
Cell protocols are aligned with the research principles established by the Indian Council of Medical Research (ICMR).
Institutional Ethics Clearance
Every protocol operates under active oversight by registered hospital ethics committees.
Pre-Procedure Safety Screen
Complete pulmonary function tests (PFT), cardiac clearance, and blood work prior to any intervention.
10. Frequently Asked Questions

Frequently Asked Questions (FAQs)

Common questions regarding stem cell evaluation, protocols, safety, and expected outcomes for ALS:

While it isn't a permanent cure, stem cell therapy is designed to slow down disease progression and help maintain your independence for longer. The treatment primarily focuses on protecting your surviving motor neurons and reducing harmful inflammation in the spinal cord (Lin et al., 2022).
Stem cells naturally seek out damaged areas in your nervous system to release healing proteins called neurotrophic factors (Goutman et al., 2019). This process creates a healthier, less toxic environment that actively protects your nerve cells from rapid deterioration.
Yes, treating ALS with mesenchymal stem cells is generally considered very safe, minimally invasive, and carries a low risk of adverse side effects. Clinical studies consistently show that the therapy is well-tolerated and focuses heavily on patient safety and comfort (Sharma et al., 2020).

Every patient responds differently, but many notice a stabilization in their symptoms or slight improvements in energy within 3 to 6 months. It works gradually alongside your body’s natural healing rhythm to potentially improve your overall quality of life (Mao et al., 2015).

Patients who are in the early to moderate stages of ALS typically experience the most encouraging benefits from stem cell interventions. Our medical team will thoroughly review your complete health history to ensure this therapy is a safe and suitable option for you.

Absolutely, stem cell therapy yields the best outcomes when paired with standard FDA-approved medications and ongoing neurorehabilitation (Sharma et al., 2020). Think of it as a powerful companion to your current care plan, rather than a total replacement.

Evidence-Based Medicine

Peer-Reviewed Scientific Citations & Clinical References

Key published clinical studies, trials, and peer-reviewed literature supporting cellular therapy and neuroprotective protocols in Amyotrophic Lateral Sclerosis (ALS). Click any reference below to view the official journal or PubMed publication:

Ref 2 Goutman, S. A., Savelieff, M. G., Sakowski, S. A., & Feldman, E. L. (2019)
Neurotherapeutics, 16(1): 130–142. DOI: 10.1007/s13311-018-00691-w
Ref 3 Sharma, A., Sane, H., Gokulchandran, N., et al. (2020)
Journal of Stem Cell Research & Therapy, 10(2): 485. DOI: 10.35248/2157-7633.20.10.485
FAST-TRACK EVALUATION

Check Eligibility for ALS (Amyotrophic Lateral Sclerosis)

Send your diagnostic reports. Senior specialists in India will review and provide a free medical opinion within 24 hours.

Request Free Treatment Plan Instant WhatsApp Chat
PARTNER HOSPITALS TREATING ALS (AMYOTROPHIC LATERAL SCLEROSIS):
Stem Cell Therapy Center - New Delhi NCR
New Delhi & Gurgaon
JCI / NABH
Advanced Regenerative Institute - Mumbai
Mumbai, Maharashtra
JCI / NABH
Stem Cell Center of Excellence - Bangalore
Bangalore, Karnataka
JCI / NABH
RELATED NEUROLOGY & BRAIN HEALTH:
Alzheimer's Disease Ataxia (Cerebellar & Spinocerebellar) Cerebral Palsy
COMPLIMENTARY CLINICAL ASSESSMENT

Get Free Medical Consultation & Cost Estimate

Submit your medical details or reports for a prompt, confidential review by India's senior specialists.

DIRECT MEDICAL DESK

Speak with a Counselor

Our international patient coordinators are available 24/7 across multiple time zones.

Response turnaround in 24 to 48 hours
HIPAA & GDPR confidential security
Accredited Locations:
Delhi NCR • Mumbai • Bangalore • Chennai
Drop files here or browse (PDF, JPG, PNG up to 25MB)
Your medical data is protected under HIPAA & GDPR privacy standards.